These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 15687885)

  • 21. Translatability of helminth therapy in inflammatory bowel diseases.
    Weinstock JV; Elliott DE
    Int J Parasitol; 2013 Mar; 43(3-4):245-51. PubMed ID: 23178819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New and emerging therapies for inflammatory bowel diseases.
    Grimm MC
    J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S69-74. PubMed ID: 19799702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Worms in prevention of allergy].
    Toppila-Salmi S; Haahtela T; Mäikelä M; Renkonen R
    Duodecim; 2013; 129(10):1023-30. PubMed ID: 23767133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The therapeutic helminth?
    McKay DM
    Trends Parasitol; 2009 Mar; 25(3):109-14. PubMed ID: 19167926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A time course study of immunological responses in Trichuris suis infected pigs demonstrates induction of a local type 2 response associated with worm burden.
    Kringel H; Iburg T; Dawson H; Aasted B; Roepstorff A
    Int J Parasitol; 2006 Jul; 36(8):915-24. PubMed ID: 16750534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammation and the mucosal microcirculation in inflammatory bowel disease: the ebb and flow.
    Danese S
    Curr Opin Gastroenterol; 2007 Jul; 23(4):384-9. PubMed ID: 17545773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of cytokine mRNA expression in intestinal biopsies of cats with inflammatory enteropathy using quantitative real-time RT-PCR.
    Nguyen Van N; Taglinger K; Helps CR; Tasker S; Gruffydd-Jones TJ; Day MJ
    Vet Immunol Immunopathol; 2006 Oct; 113(3-4):404-14. PubMed ID: 16879876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune therapy in inflammatory bowel disease and models of colitis.
    Singh B; Powrie F; Mortensen NJ
    Br J Surg; 2001 Dec; 88(12):1558-69. PubMed ID: 11736965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adaptive immunity in inflammatory bowel disease: state of the art.
    Kaser A; Blumberg RS
    Curr Opin Gastroenterol; 2008 Jul; 24(4):455-61. PubMed ID: 18622159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pathophysiologic rationale for biological therapies in inflammatory bowel disease.
    Gordon JN; Di Sabatino A; Macdonald TT
    Curr Opin Gastroenterol; 2005 Jul; 21(4):431-7. PubMed ID: 15930983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-27R deficiency delays the onset of colitis and protects from helminth-induced pathology in a model of chronic IBD.
    Villarino AV; Artis D; Bezbradica JS; Miller O; Saris CJ; Joyce S; Hunter CA
    Int Immunol; 2008 Jun; 20(6):739-52. PubMed ID: 18375937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The plant sterol guggulsterone attenuates inflammation and immune dysfunction in murine models of inflammatory bowel disease.
    Mencarelli A; Renga B; Palladino G; Distrutti E; Fiorucci S
    Biochem Pharmacol; 2009 Nov; 78(9):1214-23. PubMed ID: 19555671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intestinal fibrosis in inflammatory bowel disease: progress in basic and clinical science.
    Rieder F; Fiocchi C
    Curr Opin Gastroenterol; 2008 Jul; 24(4):462-8. PubMed ID: 18622160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intestinal helminths: a clue explaining the low incidence of inflammatory bowel diseases in Subsaharan Africa? Potential benefits and hazards of helminth therapy.
    Fiasse R; Latinne D
    Acta Gastroenterol Belg; 2006; 69(4):418-22. PubMed ID: 17343086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prebiotics, probiotics and helminths: the 'natural' solution?
    Guarner F
    Dig Dis; 2009; 27(3):412-7. PubMed ID: 19786773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New knowledge on the pathogenesis of chronic inflammatory bowel diseases: what have we learned from colitis animal models?].
    Seibold F; Egger B; Göke B
    Schweiz Med Wochenschr; 2000 May; 130(20):749-55. PubMed ID: 10920852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mouse models of intestinal inflammation as tools to understand the pathogenesis of inflammatory bowel disease.
    Uhlig HH; Powrie F
    Eur J Immunol; 2009 Aug; 39(8):2021-6. PubMed ID: 19672896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trichuris suis ova in inflammatory bowel disease.
    Schölmerich J
    Dig Dis; 2013; 31(3-4):391-5. PubMed ID: 24246995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nucleotide-binding-oligomerization domain proteins and toll-like receptors: sensors of the inflammatory bowel diseases' microbial environment.
    Mueller T; Podolsky DK
    Curr Opin Gastroenterol; 2005 Jul; 21(4):419-25. PubMed ID: 15930981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone in inflammatory bowel disease.
    De Pascalis B; Bianchi A; Satta MA; Lupascu A; Mentella MC; Leo D; Fiore F; Fedeli P; Pontecorvi A; Pola P; Melina D; Gasbarrini A; De Marinis L; Armuzzi A
    Eur Rev Med Pharmacol Sci; 2006; 10(1):13-6. PubMed ID: 16494105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.